Stockscreener 앱 받기
1.535
5.48%
0.075
전일 마감가:
$1.46
열려 있는:
$1.42
하루 거래량:
10,418
Relative Volume:
0.01
시가총액:
$5.63M
수익:
$2.86M
순이익/손실:
$-2.20M
주가수익비율:
-2.0224
EPS:
-0.759
순현금흐름:
$-1.38M
1주 성능:
+8.45%
1개월 성능:
+13.24%
6개월 성능:
-35.29%
1년 성능:
-39.37%
1일 변동 폭
$1.42
$1.50
1주일 범위
$1.31
$1.5613
52주 변동 폭
$1.0266
$3.79
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
명칭
Cyclerion Therapeutics Inc
전화
617-621-7722
주소
301 BINNEY STREET, CAMBRIDGE, MA
Compare CYCN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
1.48 | 5.56M | 2.86M | -2.20M | -1.38M | -0.759 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.35 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
740.17 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.80 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.47 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
281.99 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-20 | 개시 | Truist | Buy |
| 2021-09-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-03 | 개시 | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc 주식(CYCN)의 최신 뉴스
Cyclerion Therapeutics Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
CYCN Forecast, Price Target & Analyst Ratings | CYCLERION THERAPEUTICS INC (NASDAQ:CYCN) - ChartMill
Shorts Report: What is the target price for Cyclerion Therapeutics Inc stockMarket Trend Summary & AI Enhanced Execution Alerts - baoquankhu1.vn
CYCN Earnings History & Surprises | EPS & Revenue Results | CYCLERION THERAPEUTICS INC (NASDAQ:CYCN) - ChartMill
CYCN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cyclerion Therapeutics (CYCN) to Release Earnings on Tuesday - Defense World
CYCN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cyclerion Therapeutics (CYCN) Price Target Increased by 100.00% to 8.16 - Nasdaq
CYCN: Positive Feedback from FDA Sets Stage for Phase 2 Trial of CYC-126 in 2H26 - Research Tree
Tech Rally: Is Cyclerion Therapeutics Inc stock a good pick for beginnersJuly 2025 Final Week & Community Consensus Trade Signals - baoquankhu1.vn
Is Cyclerion Therapeutics Inc. stock a good pick for beginnersJuly 2025 Update & High Conviction Buy Zone Alerts - mfd.ru
Mobix Labs and Peraso Engage in Talks for Possible Acquisition - Intellectia AI
Volatility Watch: Can Cyclerion Therapeutics Inc deliver alphaWall Street Watch & Entry Point Confirmation Alerts - baoquankhu1.vn
Cyclerion receives FDA feedback on depression treatment development - Investing.com Nigeria
Cyclerion To Advance CYC-126 Into Phase 2 Study For Treatment-resistant Depression - Nasdaq
Cyclerion Gains FDA Support for CYC-126 Depression Study - TipRanks
Cyclerion Therapeutics announces progress toward Cyc-126 phase 2 proof-of-concept study with FDA feedback - marketscreener.com
Cyclerion Therapeutics Announces Progress Toward CYC-126 - GlobeNewswire
Is Cyclerion Therapeutics Inc. a cyclical or defensive stockPrice Action & Scalable Portfolio Growth Ideas - mfd.ru
CYCN Technical Analysis & Stock Price Forecast - Intellectia AI
Can Cyclerion Therapeutics Inc. deliver alphaWeekly Earnings Recap & Capital Efficiency Focused Strategies - mfd.ru
Aug PreEarnings: What is the target price for Cyclerion Therapeutics Inc stockAnalyst Upgrade & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Brokers Offer Predictions for CYCN FY2025 Earnings - Defense World
CYCN Should I Buy - Intellectia AI
Profit Recap: What is Cyclerion Therapeutics Incs market position2025 Market Outlook & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Investor Mood: Why is Hello Group Inc Depositary Receipt stock going downJuly 2025 Weekly Recap & Target Return Focused Picks - baoquankhu1.vn
Top Penny Stocks To Follow NowJanuary 6th - MarketBeat
Weekly Earnings: Is Cyclerion Therapeutics Inc attractive for institutional investorsWatch List & Consistent Return Investment Signals - baoquankhu1.vn
Is Cyclerion Therapeutics Inc. stock a safe buy before earningsJuly 2025 Momentum & AI Based Buy and Sell Signals - Улправда
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Why Cyclerion Therapeutics Inc. stock could rally in 2025Rate Hike & Real-Time Buy Zone Alerts - Улправда
Why retail investors favor Cyclerion Therapeutics Inc. stockTreasury Yields & Daily Entry Point Trade Alerts - Улправда
Top Penny Stocks To Follow Now – January 6th - Defense World
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Will Cyclerion Therapeutics Inc. stock benefit from upcoming earnings reports2026 world cup usa national team round of 32 playmakers high defensive line expert forecast expert opinion - ulpravda.ru
Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant DepressionSlideshow (NASDAQ:CYCN) 2026-01-07 - Seeking Alpha
Exciting Surge in Cyclerion: What’s Next? - StocksToTrade
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Cyclerion Therapeutics Collaboration Sparks Curiosity - timothysykes.com
Cyclerion, Medsteer form strategic anesthetic technology alliance - TipRanks
Cyclerion Therapeutics stock jumps in premarket after Medsteer deal — what CYCN investors watch next - TechStock²
Stay updated with the stocks that are on the move in today's pre-market session. - Chartmill
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression - Sahm
Morning Market Movers: CYCN, AZI, AEVA, OS See Big Swings - RTTNews
Cyclerion (CYCN) Enters Exclusive Collaboration with Medsteer to Advance CYC-126 Clinical Trials - Intellectia AI
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Cyclerion partners with Medsteer to advance depression treatment platform - Investing.com Nigeria
Cyclerion Expands Partnership With Medsteer; Plans Phase 2 Trial Of CYC-126 In 2H 2026; Stock Up - Nasdaq
Cyclerion Therapeutics Inc (CYCN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.41%
0.27%
자본화:
|
볼륨(24시간):